- Home
- ACM vs SNN Comparison
ACM vs SNN Comparison
Compare ACM & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACM
- SNN
- Stock Information
- Founded
- ACM 1980
- SNN 1856
- Country
- ACM United States
- SNN United Kingdom
- Employees
- ACM N/A
- SNN N/A
- Industry
- ACM Military/Government/Technical
- SNN Industrial Specialties
- Sector
- ACM Consumer Discretionary
- SNN Health Care
- Exchange
- ACM Nasdaq
- SNN Nasdaq
- Market Cap
- ACM 16.3B
- SNN 13.2B
- IPO Year
- ACM 2007
- SNN 1999
- Fundamental
- Price
- ACM $124.89
- SNN $37.42
- Analyst Decision
- ACM Strong Buy
- SNN Hold
- Analyst Count
- ACM 10
- SNN 3
- Target Price
- ACM $128.50
- SNN $31.50
- AVG Volume (30 Days)
- ACM 830.2K
- SNN 900.3K
- Earning Date
- ACM 08-04-2025
- SNN 10-30-2025
- Dividend Yield
- ACM 0.83%
- SNN 1.96%
- EPS Growth
- ACM 147.22
- SNN 59.91
- EPS
- ACM 4.59
- SNN 0.56
- Revenue
- ACM $16,074,699,000.00
- SNN $5,944,000,000.00
- Revenue This Year
- ACM $2.09
- SNN $7.75
- Revenue Next Year
- ACM $5.76
- SNN $5.37
- P/E Ratio
- ACM $27.21
- SNN $33.13
- Revenue Growth
- ACM 1.50
- SNN 5.35
- 52 Week Low
- ACM $85.00
- SNN $23.69
- 52 Week High
- ACM $126.29
- SNN $37.65
- Technical
- Relative Strength Index (RSI)
- ACM 69.11
- SNN 70.69
- Support Level
- ACM $122.49
- SNN $37.02
- Resistance Level
- ACM $126.29
- SNN $37.65
- Average True Range (ATR)
- ACM 1.98
- SNN 0.34
- MACD
- ACM 0.34
- SNN -0.12
- Stochastic Oscillator
- ACM 81.72
- SNN 80.12
About ACM AECOM
Aecom is one of the largest global providers of design, engineering, construction, and management services. It serves a broad spectrum of end markets including infrastructure, water, transportation, and energy. Based in Los Angeles, Aecom has a presence in over 150 countries and employs 51,000. The company generated $16.1 billion in sales in fiscal 2024.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.